IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 87 filers reported holding IRADIMED CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,868,132 | +46.5% | 87,179 | +57.6% | 0.00% | +100.0% |
Q2 2023 | $2,640,165 | +146250.6% | 55,303 | +20.7% | 0.00% | 0.0% |
Q1 2023 | $1,804 | +7.4% | 45,834 | -22.8% | 0.00% | 0.0% |
Q4 2022 | $1,679 | -99.6% | 59,344 | +274.7% | 0.00% | – |
Q3 2022 | $476,000 | -59.9% | 15,837 | -54.7% | 0.00% | -100.0% |
Q2 2022 | $1,186,000 | -16.6% | 34,954 | +10.2% | 0.00% | 0.0% |
Q1 2022 | $1,422,000 | +276.2% | 31,716 | +182.1% | 0.00% | – |
Q3 2021 | $378,000 | -69.8% | 11,241 | -80.8% | 0.00% | -100.0% |
Q1 2020 | $1,250,000 | +12.1% | 58,561 | +22.8% | 0.00% | +200.0% |
Q4 2019 | $1,115,000 | +147.8% | 47,705 | +122.3% | 0.00% | 0.0% |
Q3 2019 | $450,000 | +64.8% | 21,455 | -12.6% | 0.00% | 0.0% |
Q4 2016 | $273,000 | -70.3% | 24,557 | -54.6% | 0.00% | -50.0% |
Q3 2016 | $919,000 | +67.4% | 54,075 | +114.4% | 0.00% | +100.0% |
Q2 2016 | $549,000 | +41.1% | 25,219 | +24.2% | 0.00% | 0.0% |
Q1 2016 | $389,000 | -14.1% | 20,300 | +25.5% | 0.00% | 0.0% |
Q4 2015 | $453,000 | – | 16,172 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nine Ten Capital Management LLC | 715,877 | $32,100,000 | 4.18% |
Soleus Capital Management, L.P. | 430,051 | $19,283,000 | 2.49% |
RESOURCE CONSULTING GROUP INC | 128,000 | $5,740,000 | 1.99% |
RK Capital | 213,200 | $9,560,000 | 1.88% |
Capital Impact Advisors, LLC | 22,797 | $1,022,000 | 0.74% |
G2 Investment Partners Management LLC | 61,326 | $2,750,000 | 0.65% |
EAM Investors, LLC | 76,179 | $3,416,000 | 0.64% |
Ranger Investment Management | 193,306 | $8,668,000 | 0.55% |
EAM Global Investors LLC | 42,885 | $1,923,000 | 0.36% |
Hillsdale Investment Management Inc. | 121,500 | $5,448,000 | 0.35% |